Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04261686 · ClinicalTrials.gov registry record · NA
Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
A NA study of Arteriovenous Fistula, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 11
- Study locations
NCT04261686 is a NA study of Arteriovenous Fistula that has completed, run by C. R. Bard. The registered enrollment target is 100 participants, below the 250-participant average among 7 other Arteriovenous Fistula trials with a reported enrollment target (60% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT04261686, a NA study of Arteriovenous Fistula, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 11
- Study locations
Study Summary
The objective of this study is to collect post-market, real-world safety and effectiveness data of the COVERA Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the arteriovenous (AV) access circuit.
Conditions Studied
Interventions
- DEVICE Covera Vascular Covered Stent
Study Locations (11)
Minnesota
- University of Minnesota Medical Center - Minneapolis
- Minnesota Vascular and Surgery Center - New Brighton
Texas
- Dallas Renal Group - Dallas
- San Antonio Kidney and Disease Access Center - San Antonio
Arizona
- Arizona Kidney Disease and Hypertension Center Medical Research Services - Phoenix
Connecticut
- Yale University - New Haven
Illinois
- Chicago Access Care - Westmont
Massachusetts
- Kidney Care & Transplant Services of New England - West Springfield
Michigan
- Michigan Vascular Center - Flint
North Carolina
- North Carolina Nephrology - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-07-03 |
| Est. Completion | 2025-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04261686
The ClinicalTrials.gov registry entry for NCT04261686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 250-participant average among 7 other Arteriovenous Fistula trials with a reported enrollment target (60% lower). The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arteriovenous Fistula appearing as the primary indexed condition, and to 1 intervention - of which Covera Vascular Covered Stent is the first listed.
NCT04261686 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Minnesota, Texas, Arizona.
Frequently Asked Questions
What is clinical trial NCT04261686 about?
NCT04261686 is a clinical study titled "Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft". The objective of this study is to collect post-market, real-world safety and effectiveness data of the COVERA Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the arteriovenous (AV) access circuit.
What is the current status of trial NCT04261686?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-07-03. Estimated completion is 2025-09-16.
What conditions does trial NCT04261686 study?
This clinical trial studies the following conditions: Arteriovenous Fistula.
What interventions are being tested in trial NCT04261686?
The interventions under investigation include: Covera Vascular Covered Stent (DEVICE).
Who is sponsoring clinical trial NCT04261686?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04261686 being conducted?
This trial has 11 study locations across Arizona, Connecticut, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arteriovenous Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
RECRUITING · NA
-
Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
-
IN.PACT™ AV Access Post-Approval Study (PAS002)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.